Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim is a global pharmaceutical company that focuses on research and development in the fields of human and animal health. Established in 1885, the company is dedicated to improving the health and quality of life for people and animals through innovative medicines and therapies. Boehringer Ingelheim operates in various therapeutic areas, including respiratory diseases, cardiovascular health, oncology, and immunology, among others. The company emphasizes a commitment to sustainability and corporate responsibility, aiming to create value for society while advancing healthcare solutions. With a strong presence in both the human and veterinary medicine sectors, Boehringer Ingelheim continues to invest in research and development to address unmet medical needs and enhance patient outcomes.

Driving directions from: